nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
|
Sun, Jong-Mu |
|
2010 |
69 |
1 |
p. 105-109 5 p. |
artikel |
2 |
A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population
|
Kim, Min Jung |
|
2010 |
69 |
1 |
p. 127-129 3 p. |
artikel |
3 |
A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer
|
Kaira, Kyoichi |
|
2010 |
69 |
1 |
p. 99-104 6 p. |
artikel |
4 |
Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy
|
Li, Jian |
|
2010 |
69 |
1 |
p. 116-122 7 p. |
artikel |
5 |
Chronic exposure to estrogen and the tobacco carcinogen NNK cooperatively modulates nicotinic receptors in small airway epithelial cells
|
Al-Wadei, Hussein A.N. |
|
2010 |
69 |
1 |
p. 33-39 7 p. |
artikel |
6 |
Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status
|
Kalikaki, Aristea |
|
2010 |
69 |
1 |
p. 110-115 6 p. |
artikel |
7 |
Comparison of four antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in non-small cell lung cancer
|
Mathieu, Anne |
|
2010 |
69 |
1 |
p. 46-50 5 p. |
artikel |
8 |
Contents
|
|
|
2010 |
69 |
1 |
p. vii-viii nvt p. |
artikel |
9 |
CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians
|
Zhan, Ping |
|
2010 |
69 |
1 |
p. 19-25 7 p. |
artikel |
10 |
Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT)
|
Trovo, Marco |
|
2010 |
69 |
1 |
p. 77-85 9 p. |
artikel |
11 |
Editorial Board
|
|
|
2010 |
69 |
1 |
p. v- 1 p. |
artikel |
12 |
EUS-FNA in the preoperative staging of non-small cell lung cancer
|
Talebian, M. |
|
2010 |
69 |
1 |
p. 60-65 6 p. |
artikel |
13 |
Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas
|
Nagashio, Ryo |
|
2010 |
69 |
1 |
p. 54-59 6 p. |
artikel |
14 |
Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial
|
Girard, Nicolas |
|
2010 |
69 |
1 |
p. 86-93 8 p. |
artikel |
15 |
KRAS mutation, KRAS–LCS6 polymorphism, and non-small cell lung cancer
|
Nelson, H.H. |
|
2010 |
69 |
1 |
p. 51-53 3 p. |
artikel |
16 |
Large cell/neuroendocrine carcinoma
|
Gollard, Russell |
|
2010 |
69 |
1 |
p. 13-18 6 p. |
artikel |
17 |
Limited contamination in the Dutch–Belgian randomized lung cancer screening trial (NELSON)
|
Baecke, Eleonora |
|
2010 |
69 |
1 |
p. 66-70 5 p. |
artikel |
18 |
New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer
|
Doebele, Robert C. |
|
2010 |
69 |
1 |
p. 1-12 12 p. |
artikel |
19 |
Pathological confirmation of primary lung cancer following breast cancer
|
Tennis, M. |
|
2010 |
69 |
1 |
p. 40-45 6 p. |
artikel |
20 |
Phase II study of a biweekly schedule of docetaxel and cisplatin in patients with metastatic non-small cell lung cancer
|
Cho, Su-Hee |
|
2010 |
69 |
1 |
p. 94-98 5 p. |
artikel |
21 |
Quantitative helical dynamic contrast enhanced computed tomography assessment of the spatial variation in whole tumour blood volume with radiotherapy in lung cancer
|
Ng, Quan-Sing |
|
2010 |
69 |
1 |
p. 71-76 6 p. |
artikel |
22 |
Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: An observation for more than 10 years
|
Min, Ji Hye |
|
2010 |
69 |
1 |
p. 123-126 4 p. |
artikel |
23 |
Thromboxane receptor α mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells
|
Wei, Jingyan |
|
2010 |
69 |
1 |
p. 26-32 7 p. |
artikel |